Navigation Links
Experian Announces Alliance With Buxton to Expand Availability of Data and Analytics
Date:3/4/2009

Alliance provides market planners with additional resources to manage through challenging economic conditions.

SCHAUMBURG, Ill., March 4 /PRNewswire/ -- Experian(R), the global information services company, today announced a strategic alliance with Buxton, the industry leader in site location and customer analytics for the retail, health care, manufacturing and public sector industries.

"In this difficult economic environment, market planners need better information, tools and advice for creating and refining their growth and business strategies," said Rick Erwin, senior vice president and general manager for Experian. "Providing Experian's data and Micromarketer Generation3(SM) technology in conjunction with Buxton's market planning industry expertise ensures that businesses looking for guidance and market optimization receive the best possible information for making critical decisions."

The agreement expands the availability of strategic location intelligence services to all types of retailers, municipalities, health care providers and consumer packaged goods companies throughout the United States.

Experian -- known for its vast array of marketing information, such as its INSOURCE(SM) consumer demographic database -- provides all the data necessary to businesses making location-based decisions. The information in INSOURCE contains more than 113 million household records, at the individual household, in addition to ZIP+4(TM) and block group levels that are updated quarterly based on actual deliverable addresses.

"Aligning with Experian provides Buxton the ability to perform analysis in over 26 countries, access to next generation household level segmentation analysis capability and access to greater than 75,000 customer lifestyle characteristics which will equip our clients with the tools they need to refine growth and business strategies," said Charles W
'/>"/>

SOURCE Experian
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
2. RIEMSER Announces Upcoming Atlanta Bone Grafting Workshop
3. China Shenghuo Announces Management Expansion and Enhanced Internal Controls
4. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
5. Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians
6. IntelliSoft Group Announces Version 9.0 Enhancing and Improving IntelliCred Software
7. The Healthcare Waste and Emergency Preparedness Coalition Announces Its Official Formation
8. Nanophase Announces Changes in Principal Officers and Directors
9. Genaera Corporation Announces 2008 Financial Results
10. IRIDEX Announces Fourth Quarter and Full Year 2008 Conference Call and Release Date
11. Misonix Announces New Sales Agency Agreement for Eastern Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... Los Angeles, CA (PRWEB) July 27, 2014 ... of Summer Tickets at The Forum in Inglewood, California on ... new album and diehard fans can expect to hear songs from ... 5 Seconds of Summer concert in Inglewood, California at The Forum ... Find tickets starting at 10:00 a.m. today local time TicketDown.com. ...
(Date:7/27/2014)... Manchester have discovered why medication to treat asthma and pneumonia ... Medicine , show that drugs widely used to treat lung ... the UK pneumonia, which is caused by an infection, affects ... serious for babies, young children, the elderly, smokers and those ... million people in the UK are affected by asthma and ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 The North ... is estimated at $1570 million in 2014, and it ... a CAGR of 4.64%. The report incorporates the factors ... detailed expectations of growth rates and projected total expenditure. ... in the global markets. Apart from the general overview ...
(Date:7/27/2014)... 27, 2014 The European Agricultural Adjuvants ... Europe with analysis and forecast of revenue. The agricultural ... around $509.4 million in 2013 to $657.1 million by ... 2018. , Browse through the TOC of the European ... the in-depth analysis provided. It also provides a glimpse ...
(Date:7/27/2014)... July 27, 2014 Metachromatic leukodystrophy ... lysosomal storage disease which is commonly listed in ... the sphingolipidoses as it affects the metabolism of ... myelin, the fatty covering which acts as an ... peripheral nervous systems. MLD involves cerebroside sulfate accumulation. ...
Breaking Medicine News(10 mins):Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2Health News:Drugs used to treat lung disease work with the body clock 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 4Health News:North America Security and Surveillance Radar Market is Expected to Reach $2030 million in 2019 - New Report by MicroMarket Monitor 5Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Agricultural Adjuvants Market is Expected to Reach $657.1 million in 2018 - New Report by MicroMarket Monitor 5Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 2Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 3Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 5
... at risk for the disease, as well as ways to prevent ... osteoporosis. ,1. MYTH: Only women get osteoporosis ... this condition, theres also a very significant portion of men who ... suffer from osteoporosis, accounting for 20 percent of those diagnosed with ...
... US-based Redux Beverages said it would be marketing. Well, only it was ... drink. ,In September last year it announced the launch ... illegal drug. ,Jamey Kirby, the drink's inventor, said the name ... session at 1 o'clock in the morning. ,"It's an ...
... how nerve cells signal to one another could rewrite the ... at Weill Cornell Medical College and Yale University. ... journal Science, suggests that a key cellular enzyme called dynamin ... had previously assumed. ,Dynamin has long been a ...
... and additional risk factors for heart disease may ... two , if their current treatment combines the ... amlodipine, researchers reported at the American Heart Association's ... Outcomes Research in Cardiovascular Disease and Stroke. ...
... The Health and Family Welfare Minister, Dr. Anbumani ... Nursing Personnel today , said that under the ... requires about 200,000 nursing personnel to provide comprehensive ... achieve the requirements of NRHM, State Governments have ...
... Sensitive issues, poignant emotions and subjects that are not ... body were the mainstay of the international film festival ... on its first day Saturday. , ,Brought ... Bharati Corporation, the Mac Arthur Foundation and UNESCO, the ...
Cached Medicine News:Health News:7 Common Myths About Osteoporosis 2Health News:7 Common Myths About Osteoporosis 3Health News:'Cocaine' Turns 'Censored' and Remains 'energy Drink' 2Health News:'Cocaine' Turns 'Censored' and Remains 'energy Drink' 3Health News:Study Revises Dynamin's Role in Nerve Cell Function 2Health News:Study Revises Dynamin's Role in Nerve Cell Function 3Health News:One Pill may Be Better Than Two for Treating Patients With High Blood Pressure 2Health News:One Pill may Be Better Than Two for Treating Patients With High Blood Pressure 3Health News:Film Festival on Gender Sexuality Draws Crowds 2
(Date:7/24/2014)... July 24, 2014  IRIDEX Corporation (NASDAQ: ... second quarter 2014 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, July 31, 2014 ... other business developments. Interested parties may access ...
(Date:7/24/2014)... July 24, 2014 Omnicell, Inc. (NASDAQ: ... medication and supply management solutions and analytics software ... July 31, to discuss the Company,s Second Quarter ... Quarter 2014 earnings conference call and webcastWhen: ... Randall Lipps, chairman, president and chief executive officer ...
(Date:7/24/2014)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based ... results for the second quarter ended June 30, 2014. ... of $6.5 million in the second quarter of 2014, an ... , Total revenues of $13.3 million for the six months ... same period in 2013 , Total revenues generated from ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... MicroCHIPS, Inc., a developer of innovative drug delivery ... Office and Trademark Office has granted U.S. Patent No. ... This patent in conjunction with U.S. Patent No. 7,070,590 ... reservoir-based medical devices used for implantable drug delivery systems. ...
... Promidian, a management consulting firm focused on ... survey findings about the increasing interest in the ... that is rapidly gaining nationwide attention for its ... care—while reducing costs. The Promidian ...
Cached Medicine Technology:MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems 2Promidian Survey Finds Growing Support for Patient-Centered Medical Home 2
... The Humphrey Field Analyzer II-i series is ... examine the patient's visual field. By using ... time is reduced by up to 70%. ... compact, ergonomic design to increase patient comfort ...
... Matrix represents the latest breakthrough in ... technology, the Humphrey Matrix will help ... evaluation and assess treatment alternatives. Enhanced ... provide complete long-term glaucoma care for ...
... Proclear Tailor Made Toric soft contact lenses let ... any other soft toric lens in a lens ... level of comfort is made possible by PC ... of phosphorylcholine (PC), a substance found naturally in ...
Preference Toric quarterly planned replacement lenses are durable, easy to handle and virtually maintenance free. Meeting the needs of those suffering from astigmatism, these soft contact lenses are ...
Medicine Products: